Incidence of idiopathic pulmonary fibrosis in Korea based on the 2011 ATS/ERS/JRS/ALAT statement

被引:12
作者
Gjonbrataj, J. [1 ,2 ]
Choi, W-I [1 ]
Bahn, Y. E. [3 ]
Rho, B. H. [3 ]
Lee, J. J. [4 ]
Lee, C. W. [5 ]
机构
[1] Keimyung Univ, Dept Internal Med, Sch Med, Daegu 700712, South Korea
[2] Mother Thereza Univ Hosp, Dept Internal Med, Tirana, Albania
[3] Keimyung Univ, Dept Radiol, Sch Med, Daegu 700712, South Korea
[4] Kyungbuk Natl Univ, Dept Stat, Daegu, South Korea
[5] Hankook Gen Hosp, Dept Occupat & Environm Med, Cheongju, South Korea
关键词
epidemiology; IPF; interstitial lung disease; usual interstitial pneumonia; INTERSTITIAL LUNG-DISEASES; EPIDEMIOLOGY; DIAGNOSIS; HEALTH; REGISTRATION; PREVALENCE; MORTALITY;
D O I
10.5588/ijtld.14.0650
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
OBJECTIVE: To estimate the annual incidence rate of interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF) in Korea. DESIGN: A retrospective cohort design using the Korean Health Insurance Review and Assessment Service (HERA) database spanned the period from January 2008 to December 2012. Patients with ILD and IPF were identified based on the International Classification of Disease-10 (ICD-10) diagnosis and procedure codes. Definition 1 is code J84 (ILD); Definition 2 is code J84 plus high-resolution computed tomography (HRCT), bronchoalveolar lavage (BAL) or lung biopsy; Definition 3 is code J84.1 (ILD with fibrosis); Definition 4 is code J84.1 and HRCT, BAL or lung biopsy; and Definition 5 is code J84.1A (IPF), and was specifically implemented for IPF. RESULTS: The incidence rates of lLD per 100 000 population based on Definitions 1-5 were respectively 48.5, 32.2, 16.2, 11.4 and 1.7. CONCLUSION: The incidence of ILD with fibrosis was approximately 23% of overall ILD incidence. IPF incidence was approximately 10% of the incidence of lLD with fibrosis. Based on the new ATS/ERS/JRS/ALAT statement published in 2011, the incidence rate of IPF was 1.7/100 000.
引用
收藏
页码:742 / 746
页数:5
相关论文
共 30 条
[1]  
Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646
[2]  
ATS/ERS, 2002, AM J RESP CRIT CARE, V165, P277, DOI [10.1164/ajrccm.165.2.ats01, DOI 10.1164/AJRCCM.165.2.ATS01, DOI 10.1164/ajrccm.165.2.ats01]
[3]  
CARRINGTON CB, 1976, CHEST, V69, P261
[4]  
Costabel U, 1996, Pneumologie, V50 Suppl 2, P611
[5]   THE EPIDEMIOLOGY OF INTERSTITIAL LUNG-DISEASES [J].
COULTAS, DB ;
ZUMWALT, RE ;
BLACK, WC ;
SOBONYA, RE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (04) :967-972
[6]  
Demedts M, 2001, EUR RESPIR J, V18, p2S
[7]   Idiopathic interstitial pneumonia - What is the effect of a multidisciplinary approach to diagnosis? [J].
Flaherty, KR ;
King, TE ;
Raghu, G ;
Lynch, JP ;
Colby, TV ;
Travis, WD ;
Gross, BH ;
Kazerooni, EA ;
Toews, GB ;
Long, Q ;
Murray, S ;
Lama, VN ;
Gay, SE ;
Martinez, FJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) :904-910
[8]   Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK [J].
Gribbin, J. ;
Hubbard, R. B. ;
Le Jeune, I. ;
Smith, C. J. P. ;
West, J. ;
Tata, L. J. .
THORAX, 2006, 61 (11) :980-985
[9]  
Herman Miroslav, 1993, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V135, P25
[10]   Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland [J].
Hodgson, U ;
Laitinen, T ;
Tukiainen, P .
THORAX, 2002, 57 (04) :338-342